Daily US Conference Schedule for September 30, 2026
Newsquawk ·
The daily agenda for US equity conferences scheduled on September 30, 2026, highlights several key corporate presentations across various sectors. Eli Lilly and Company (LLY) takes the stage at the 2026 EASD Annual Meeting, running from September 28, 2026, through October 2, 2026. Faraday Future Intelligent Electric Inc. (FFAI) presents at the IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS) following an event on September 29, 2026, at 05:01 PM. Meanwhile, Avalo Therapeutics, Inc. (AVTX) features at the EADV Congress 2026 from September 30 through October 3, 2026. Additional corporate updates are slated from Opus Genetics, Inc. (IRD) at the Euretina Innovation Spotlight, Lexeo Therapeutics, Inc. (LXEO) and Amylyx Pharmaceuticals, Inc. (AMLX) at the Stifel 2026 Virtual Cardiometabolic Forum, and Eversource Energy (ES) at the Wolfe Research Utilities, Midstream and Clean Energy Conference 2026-Virtual.
AI 시장 분석
The U.S. stock market conference schedule for September 30, 2026, includes presentations from major companies such as LLY (Eli Lilly), FFAI, and AVTX. This schedule focuses on clinical data and new technology announcements from biotech and electric vehicle companies. Investors need to pay attention to short-term stock price volatility resulting from each company's presentations.
상승 영향
- Biotech — LLY and numerous pharmaceutical companies are presenting major clinical data and research results at conferences, which could raise expectations for new drug development.
DYAX 전담 분석
This conference schedule serves as a catalyst for individual stock momentum through presentations by biotech and EV companies. In particular, academic presentations by major pharmaceutical companies like LLY directly impact sentiment in related sectors.
In the bullish scenario, an influx of buying is expected due to the release of new drug data, while in the bearish scenario, profit-taking may occur if expectations are missed. Key presentation sessions and clinical results must be monitored closely.
AI가 생성한 분석으로 투자 자문이 아닙니다.
DYAX Investor Sentiment
Bullish (Long) 55% · Bearish (Short) 45%
360 participants
Related News
- Warren Buffett Reveals One Fundamental Rule to Withstand Market Crashes
- OpenAI Teases New Models as Altman Critiques Nvidia Security Framework
- Alex Sirois Re-enters Taiwan Semiconductor Investment
- Meta Launches New Forum App for iOS and Android in the US
- Apple Shares Drop as Bank of America Highlights Emerging AI Commerce Risks
- Nvidia Allocates Record $150 Billion to Share Buyback Amid AI Safety Debate
